What is the CJC-1295 + Ipamorelin stack?

The CJC-1295 + Ipamorelin stack is the most widely used growth hormone (GH) secretagogue combination, often called the "Gold Standard GH Stack." CJC-1295 (no DAC) is a GHRH analog that amplifies GH pulse amplitude, while Ipamorelin is a ghrelin mimetic (GHRP) that triggers a clean GH release without significantly raising cortisol or prolactin. Together they produce a synergistic GH pulse substantially greater than either peptide alone.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 comes in two forms: with DAC (Drug Affinity Complex) and without DAC (also called Modified GRF 1-29 or Mod GRF). The no-DAC version has a short half-life of about 30 minutes and produces distinct, pulsatile GH releases that mimic natural physiology. The DAC version has a half-life of 6–8 days and creates sustained, elevated GH levels around the clock. For this stack, the no-DAC version is strongly preferred because it preserves natural GH pulsatility and pairs correctly with Ipamorelin’s acute signaling.

Why do I need to fast before injecting?

Food intake — particularly carbohydrates and fats — raises blood sugar and insulin levels, which directly suppresses growth hormone release. Insulin and GH are antagonistic: when insulin is high, the pituitary blunts its GH output. Injecting CJC-1295 + Ipamorelin on an empty stomach (at least 2–3 hours fasted) ensures that insulin is low, allowing the full GH pulse to occur. Eating within 30–60 minutes after injection can also blunt the tail end of the GH release.

Can I inject CJC-1295 and Ipamorelin in the same syringe?

Yes. Unlike some peptide combinations, CJC-1295 (no DAC) and Ipamorelin are commonly drawn into the same syringe and injected together. This is standard practice in the community and does not appear to reduce the efficacy of either peptide. Draw the desired dose from each reconstituted vial into one insulin syringe and inject subcutaneously.

How long does the CJC-1295 + Ipamorelin stack take to show results?

Most users notice improved sleep quality within the first 1–2 weeks. Deeper, more restorative sleep is typically the earliest reported benefit. Body composition changes (reduced body fat, improved muscle tone) usually become noticeable at 4–6 weeks. Recovery improvements may appear as early as 2–3 weeks. Anti-aging benefits such as improved skin quality and hair thickness generally require 8–12 weeks of consistent use.

When is the best time to inject?

The most popular injection time is before bed, at least 2–3 hours after your last meal. This synergizes with the body’s natural nocturnal GH pulse, which is the largest of the day. The second most common time is first thing in the morning while still fasted. Some users add a third injection 20–30 minutes before exercise on an empty stomach. Consistency in timing matters more than the specific time chosen.

Will this stack show up on a drug test?

Both CJC-1295 and Ipamorelin are prohibited by the World Anti-Doping Agency (WADA) and most professional sports organizations. They fall under the category of Growth Hormone Releasing Factors. Advanced testing methods can detect synthetic GHRH analogs and ghrelin mimetics. Athletes subject to anti-doping testing should not use this stack.

Do I need PCT (post-cycle therapy) after this stack?

No. CJC-1295 + Ipamorelin stimulate your own pituitary gland to produce and release growth hormone — they do not introduce exogenous GH or suppress your natural GH axis in the way that anabolic steroids suppress testosterone. When you stop the peptides, your pituitary simply returns to its baseline GH output. No PCT is required.

Can I use this stack with other peptides?

Yes. CJC-1295 + Ipamorelin is commonly combined with other peptides depending on goals. For healing: add BPC-157 + TB-500 (inject at different times, as GH peptides require fasting). For fat loss: some users add Tesamorelin, a GHRH analog with specific lipolytic effects. For sleep: DSIP can complement the nocturnal GH protocol. Always research interactions before combining and keep total peptide complexity manageable.

Is exogenous HGH better than CJC-1295 + Ipamorelin?

They work differently. Exogenous HGH delivers a fixed dose of growth hormone directly, bypassing the pituitary entirely. CJC-1295 + Ipamorelin stimulate your pituitary to release its own GH in natural pulses. Advantages of the peptide stack include preserved pulsatile release pattern, lower cost, fewer side effects (less insulin resistance, less water retention), and maintained pituitary function. Exogenous HGH provides more predictable and higher absolute GH levels. Many users prefer the peptide stack for its cleaner side-effect profile and more physiological approach.

How many vials do I need for a full cycle?

For a standard 8-week cycle at 100 mcg each, once daily before bed: you need 5,600 mcg (5.6 mg) of each peptide. That is approximately three 2 mg vials or two 5 mg vials of each peptide. If dosing twice daily (morning and bedtime), double those amounts. Purchase one extra vial of each to account for priming losses and vial dead space.

What should I do if I experience water retention or numbness?

Mild water retention and tingling or numbness in the hands (carpal tunnel-like symptoms) are signs that GH levels are elevated and are the most common side effects. They typically resolve within the first 2–3 weeks as your body adjusts. If symptoms are uncomfortable, reduce the dose by 50% for one week, then titrate back up. If symptoms persist or worsen, discontinue use and consult a healthcare provider. Staying well-hydrated and moderating sodium intake can help manage water retention.

CJC-1295 + Ipamorelin Stack Guide

The Gold Standard GH Stack — the most popular growth hormone secretagogue combination for optimizing sleep, body composition, recovery, and anti-aging. Complete dosing protocols, timing, reconstitution, and safety for CJC-1295 (no DAC) and Ipamorelin together.

Compiled by PeptideWiki Editorial Team

Stack Overview

The CJC-1295 + Ipamorelin combination — commonly called the “Gold Standard GH Stack” — is the most widely used growth hormone secretagogue stack for optimizing natural GH production. It pairs CJC-1295's ability to amplify GH pulse amplitude (as a GHRH analog) with Ipamorelin's clean, selective GH release (as a ghrelin mimetic) to produce a synergistic GH pulse significantly greater than either peptide alone.

Key Characteristics:

2-peptide stack — CJC-1295 without DAC (Modified GRF 1-29) + Ipamorelin (selective ghrelin mimetic/GHRP)
Primary goal — growth hormone optimization — improved sleep quality, body composition, recovery, anti-aging, and overall well-being
Complementary mechanisms — CJC-1295 amplifies GH pulse amplitude via GHRH receptor activation; Ipamorelin triggers a clean GH pulse via the ghrelin receptor without raising cortisol or prolactin
Experience level — suitable for beginners; one of the most well-documented and well-tolerated GH peptide stacks
Typical cycle — 8–12 weeks on, 4 weeks off. No loading phase required.
Administration — subcutaneous injection, both peptides injected together on an empty stomach (fasted state required)

Use our Peptide Dosage Calculator to calculate exact doses for both peptides based on your vial sizes and reconstitution volumes.

Important: Neither CJC-1295 nor Ipamorelin is FDA-approved for human use. Both are classified as research peptides. All dosing information in this guide is derived from clinical research on GH secretagogues and community protocols — not from large-scale human clinical trials of this specific combination. Consult a healthcare provider before using any research peptide.

Why This Stack Works

The CJC-1295 + Ipamorelin stack is effective because it stimulates growth hormone release through two independent but synergistic pathways. Rather than relying on a single receptor system, this combination activates both the GHRH and ghrelin pathways simultaneously, producing a GH pulse that is significantly larger than either peptide can achieve alone.

CJC-1295 (no DAC): The Amplifier

GHRH receptor agonist: binds to GHRH receptors on pituitary somatotroph cells, stimulating them to produce and release growth hormone
Pulse amplitude: increases the amplitude (size) of each GH pulse without disrupting the natural pulsatile pattern
Short half-life (~30 min): the no-DAC form produces discrete GH pulses that mimic natural physiology, unlike the DAC version which creates sustained elevation
IGF-1 elevation: sustained use increases circulating IGF-1 levels, supporting tissue repair, muscle protein synthesis, and fat metabolism

Ipamorelin: The Clean Trigger

Ghrelin receptor agonist (GHRP): mimics the hunger hormone ghrelin to trigger GH release from a completely different receptor than CJC-1295
Selective GH release: unlike other GHRPs (GHRP-2, GHRP-6, Hexarelin), Ipamorelin does not significantly elevate cortisol or prolactin, making it the cleanest GHRP available
Dose-dependent response: produces a predictable, dose-dependent GH release with minimal desensitization over time
Mild hunger signaling: may slightly increase appetite through ghrelin mimicry, but far less than GHRP-6 or GHRP-2

The Synergy

CJC-1295 tells the pituitary “make more GH and release bigger pulses” via the GHRH pathway. Ipamorelin simultaneously tells the pituitary “release GH now” via the ghrelin pathway. When both signals arrive together, the pituitary responds with a GH pulse that is substantially larger than either signal could produce alone. Research on GHRH + GHRP combinations has demonstrated this synergistic effect, with combined administration producing GH output that exceeds the simple sum of each peptide's individual effect.

Evidence note: The synergy between GHRH analogs and GHRPs is well-established in clinical research. Studies on GHRH + GHRP combinations consistently show supra-additive GH release. The specific CJC-1295 (no DAC) + Ipamorelin combination is primarily supported by this broader GHRH/GHRP synergy research and extensive community experience.

Individual Peptide Breakdown

Each peptide in this stack has a dedicated dosage guide with complete individual protocols. Here is a summary of each peptide's role in this stack.

CJC-1295 (Modified GRF 1-29, no DAC)

Type: Synthetic GHRH analog (29 amino acids, modified for stability)
Origin: Modified version of the first 29 amino acids of endogenous GHRH
Role in stack: Amplifies GH pulse amplitude via GHRH receptor activation
Route: Subcutaneous injection
Frequency: 1–3 times daily (fasted)

Full CJC-1295 Dosage Guide →

Ipamorelin (Selective GHRP)

Type: Synthetic pentapeptide ghrelin mimetic (5 amino acids)
Origin: Designed as a selective growth hormone secretagogue with minimal side effects
Role in stack: Triggers clean GH release via ghrelin receptor without cortisol/prolactin elevation
Route: Subcutaneous injection
Frequency: 1–3 times daily (fasted)

Full Ipamorelin Dosage Guide →

Dosing Protocol

CJC-1295 and Ipamorelin are dosed at the same frequency and injected together in the same syringe. The standard dose range is 100–300 mcg of each peptide per injection, taken 1–3 times daily on an empty stomach.

Standard Protocol (Most Common)

Compound	Dose	Frequency	Route	Notes
CJC-1295	100 mcg	Once daily (before bed)	SubQ (abdomen)	Inject fasted, at least 2–3 hours after last meal
Ipamorelin	100 mcg	Once daily (before bed)	SubQ (abdomen)	Can be combined in the same syringe as CJC-1295

Accelerated Protocol (Twice Daily)

Compound	Dose	Frequency	Route	Notes
CJC-1295	100–200 mcg	Twice daily	SubQ (abdomen)	Morning (fasted) + before bed (fasted)
Ipamorelin	100–200 mcg	Twice daily	SubQ (abdomen)	Same syringe as CJC-1295 at each injection

Advanced Protocol (Three Times Daily)

Compound	Dose	Frequency	Route	Notes
CJC-1295	100 mcg	Three times daily	SubQ (abdomen)	Morning fasted + pre-workout fasted + before bed fasted
Ipamorelin	100 mcg	Three times daily	SubQ (abdomen)	Same syringe as CJC-1295 at each injection

Protocol selection: Start with the standard protocol (100 mcg each, once daily before bed) for your first cycle. This is effective, simple, and allows you to assess tolerance. Move to twice daily for subsequent cycles if you want stronger results. The three-times-daily protocol is for experienced users with specific body composition or recovery goals.

Calculate Your Doses

Both peptides are supplied as lyophilized powder and need reconstitution with bacteriostatic water. The dose you draw depends on the concentration after reconstitution.

CJC-1295 (no DAC) — 2 mg Vial

Vial size: 2 mg (2,000 mcg)
Bacteriostatic water: 2 mL
Concentration: 2,000 ÷ 2 = 1,000 mcg/mL
100 mcg dose = 0.1 mL = 10 units on insulin syringe
Doses per vial: 20 doses at 100 mcg

CJC-1295 (no DAC) — 5 mg Vial

Vial size: 5 mg (5,000 mcg)
Bacteriostatic water: 2.5 mL
Concentration: 5,000 ÷ 2.5 = 2,000 mcg/mL
100 mcg dose = 0.05 mL = 5 units on insulin syringe
Doses per vial: 50 doses at 100 mcg

Ipamorelin — 2 mg Vial

Vial size: 2 mg (2,000 mcg)
Bacteriostatic water: 2 mL
Concentration: 2,000 ÷ 2 = 1,000 mcg/mL
100 mcg dose = 0.1 mL = 10 units on insulin syringe
Doses per vial: 20 doses at 100 mcg

Ipamorelin — 5 mg Vial

Vial size: 5 mg (5,000 mcg)
Bacteriostatic water: 2.5 mL
Concentration: 5,000 ÷ 2.5 = 2,000 mcg/mL
100 mcg dose = 0.05 mL = 5 units on insulin syringe
Doses per vial: 50 doses at 100 mcg

Skip the Math — Use Our Calculator

Enter your vial size, water volume, and desired dose for each peptide — get instant calculations with zero manual math.

Reconstitution Guide

Both peptides follow the same reconstitution process. Reconstitute each vial separately with bacteriostatic water.

Peptide	Vial Size	Bac Water	Concentration	Standard Dose Draw
CJC-1295	2 mg	2 mL	1,000 mcg/mL	10 units (0.1 mL) for 100 mcg
CJC-1295	5 mg	2.5 mL	2,000 mcg/mL	5 units (0.05 mL) for 100 mcg
Ipamorelin	2 mg	2 mL	1,000 mcg/mL	10 units (0.1 mL) for 100 mcg
Ipamorelin	5 mg	2.5 mL	2,000 mcg/mL	5 units (0.05 mL) for 100 mcg

Wash Hands & Prepare Workspace

Wash hands thoroughly. Lay out supplies: peptide vials, bacteriostatic water, insulin syringes, and alcohol swabs on a clean surface.

Swab Both Vial Stoppers

Remove plastic caps and swab the rubber stoppers of the peptide vial and bacteriostatic water vial with alcohol pads. Let air-dry for 10–15 seconds.

Add Water to Peptide Vial

Draw the appropriate volume of bacteriostatic water. Insert needle into peptide vial and direct the stream down the inside glass wall — never squirt directly onto the powder. Release slowly.

Dissolve Gently

Let the vial sit for 1–2 minutes, then gently swirl or roll between palms until fully dissolved. Solution should be clear and colorless. Never shake.

Label & Refrigerate

Write the reconstitution date, peptide name, and concentration on each vial. Store refrigerated at 2–8°C. Use within 28–30 days.

For a detailed visual walkthrough, see our Reconstitution Guide.

Timing & Daily Schedule

Timing is critical for this stack. Both peptides must be injected on an empty stomach to avoid insulin-mediated GH suppression. Here is how a typical day looks for each protocol:

Once Daily Protocol (Bedtime)

Time	Action	Notes
7:00 PM	Last meal of the day	Finish eating at least 2–3 hours before injection
9:30–10:00 PM	Inject CJC-1295 (100 mcg) + Ipamorelin (100 mcg)	Combined in one syringe, SubQ in abdomen
10:00–10:30 PM	Sleep	GH pulse synergizes with natural nocturnal release

Twice Daily Protocol (Morning + Bedtime)

Time	Action	Notes
6:30–7:00 AM	Inject CJC-1295 (100 mcg) + Ipamorelin (100 mcg)	Immediately upon waking, while still fasted
7:00–7:30 AM	Wait 20–30 minutes, then eat breakfast	Allow GH pulse to peak before introducing food
7:00 PM	Last meal of the day	Finish eating 2–3 hours before bedtime injection
9:30–10:00 PM	Inject CJC-1295 (100 mcg) + Ipamorelin (100 mcg)	Combined in one syringe, SubQ in abdomen

Timing Notes

Fasting is non-negotiable: Always inject at least 2–3 hours after your last meal. Food (especially carbs) raises insulin and blunts the GH pulse.
Bedtime is the highest-value injection: If dosing only once daily, choose bedtime. This synergizes with the natural nocturnal GH pulse, which is the body's largest daily GH release.
Post-injection eating window: Wait at least 20–30 minutes after injection before eating. If injecting before bed, simply go to sleep (no food needed).
Pre-workout timing: If adding a third daily injection, inject 20–30 minutes before exercise on an empty stomach. The GH pulse may enhance workout performance and recovery.

Consistency matters: Inject at the same time(s) every day for the entire cycle. GH secretagogue stacks work through consistent, cumulative stimulation of the pituitary. Irregular dosing reduces overall effectiveness.

Cycling & Duration

The CJC-1295 + Ipamorelin stack is typically run for 8–12 weeks followed by a 4-week break. No loading phase is needed — both peptides are effective from the first injection.

Phase	Duration	CJC-1295	Ipamorelin
Active Cycle	Weeks 1–8 (or 1–12)	100–300 mcg, 1–3x daily	100–300 mcg, 1–3x daily
Break	4 weeks off	None	None
Repeat (if desired)	8–12 weeks	Resume protocol	Resume protocol

Cycle Length Guidance

8 weeks: Minimum recommended cycle length. Sufficient for sleep improvement, early body composition changes, and recovery benefits.
10–12 weeks: Preferred for body composition goals (fat loss, muscle tone), anti-aging benefits (skin quality, hair), and IGF-1 elevation. Most community protocols target this range.
Beyond 12 weeks: Some users run extended cycles of 16–20 weeks. While no tolerance buildup has been definitively established, periodic breaks are recommended to maintain receptor sensitivity and assess progress.

Why Take a Break?

The break period serves several purposes: (1) maintain pituitary sensitivity to GHRH and ghrelin signaling, (2) assess your baseline status without peptide support to confirm lasting benefits, (3) reduce cumulative exposure to research compounds, and (4) reset any mild side effects like water retention that may have developed. Most users find that sleep quality and recovery improvements persist for several weeks into the break period.

Safety, Side Effects & Contraindications

Safety profile: CJC-1295 + Ipamorelin is considered one of the best-tolerated peptide stacks. Ipamorelin in particular was designed for selectivity — it triggers GH release without significantly elevating cortisol, prolactin, or aldosterone. Most users experience minimal or no side effects at standard doses.

Common Side Effects

Water retention — mild fluid retention, especially in the first 1–2 weeks. Usually resolves as the body adjusts.
Tingling or numbness in hands — carpal tunnel-like symptoms from elevated GH. A sign the peptides are working. Dose-dependent.
Increased hunger — Ipamorelin is a ghrelin mimetic and may mildly increase appetite, though far less than GHRP-6 or GHRP-2.
Mild headache — occasionally reported in the first few days of use. Usually transient.
Injection site redness or irritation — minor and temporary at SubQ injection sites.
Fatigue or drowsiness — some users feel sleepy after bedtime injection, which is typically considered a benefit rather than a side effect.

Contraindications

Active cancer or history of cancer: Growth hormone promotes cell proliferation and can accelerate tumor growth. Do not use GH secretagogues with active malignancies or unmonitored cancer history.
Pregnancy and breastfeeding: No safety data exists for either peptide during pregnancy or nursing. Avoid entirely.
Diabetes (uncontrolled): GH elevation can increase insulin resistance and raise blood glucose. Diabetic users should monitor blood sugar closely and consult their physician.
Active pituitary disorders: Conditions such as pituitary tumors (including prolactinomas) or hypopituitarism may be worsened by GH secretagogue stimulation.
Children and adolescents: Manipulating the GH axis during growth and development is not recommended without direct medical supervision.

Stack-Specific Safety Notes

No known negative interaction: CJC-1295 and Ipamorelin operate through different receptors (GHRH and ghrelin respectively) and are designed to be used together.
Ipamorelin selectivity advantage: Unlike GHRP-2, GHRP-6, and Hexarelin, Ipamorelin does not significantly raise cortisol or prolactin. This makes it the preferred GHRP for this combination.
No pituitary suppression: Unlike exogenous HGH, this stack stimulates your own pituitary to release GH. It does not suppress the natural GH axis and does not require post-cycle therapy.

Regulatory status: Neither CJC-1295 nor Ipamorelin is FDA-approved for human use. Both are classified as research peptides. Both are prohibited by WADA for competitive athletes. Regulations vary by jurisdiction — verify your local laws before purchasing.

Common CJC-1295 + Ipamorelin Mistakes

Avoid these common errors to get the most out of your CJC-1295 + Ipamorelin protocol:

Eating before injection (not fasting)

Food intake raises insulin, which directly suppresses growth hormone release. Injecting within 2–3 hours of a meal — especially carbohydrates — can blunt your GH pulse by 50–80%. Always inject on an empty stomach and wait at least 20–30 minutes before eating afterward.

Using CJC-1295 WITH DAC instead of without DAC

CJC-1295 with DAC has a 6–8 day half-life and produces a constant GH elevation rather than natural pulses. It requires completely different dosing (once or twice weekly) and does not pair correctly with Ipamorelin’s acute pulsatile mechanism. The no-DAC version (Mod GRF 1-29) is the correct form for this stack.

Injecting only once per day when twice would be more effective

While once daily (before bed) is a solid starting protocol, adding a second fasted injection in the morning roughly doubles your total daily GH output. Users seeking meaningful body composition changes or recovery benefits should consider twice-daily dosing. Three times daily (morning, pre-workout, bedtime) is the maximum useful frequency.

Expecting steroid-like results

CJC-1295 + Ipamorelin optimizes your natural GH production — it does not deliver supraphysiological hormone levels like exogenous HGH or anabolic steroids. Benefits are real but gradual: improved sleep, better recovery, modest fat loss, and improved skin quality over 8–12 weeks. This is an optimization tool, not a transformation shortcut.

Storing reconstituted peptides at room temperature

Both CJC-1295 and Ipamorelin degrade rapidly at room temperature after reconstitution. Always refrigerate reconstituted vials at 2–8°C and use within 28–30 days. Unreconstituted (lyophilized) vials can be stored at room temperature short-term but should ideally be refrigerated or frozen for long-term storage.

Skipping weekends or dosing inconsistently

GH secretagogue stacks work through cumulative, consistent stimulation of the pituitary. Skipping days reduces the overall GH elevation and slows results. Dose every day at the same time(s) for the entire cycle duration. If you cannot commit to daily injections, this may not be the right protocol for you.

Using excessively high doses thinking more is better

Research suggests that GH release from GHRP/GHRH combinations reaches a saturation point around 100–200 mcg per peptide per injection. Doses above 200–300 mcg do not produce proportionally more GH but do increase side effects like water retention, numbness, and hunger. Stay within the 100–300 mcg range per peptide per injection.

Not accounting for the GH bleed when eating post-injection

After injection, the GH pulse takes approximately 20–30 minutes to peak and 60–90 minutes to fully resolve. Eating immediately after injection (especially carbohydrates) raises insulin and truncates the tail end of the GH pulse. Wait at least 20–30 minutes after injection before eating, and avoid high-glycemic foods in that first meal.

Frequently Asked Questions

Key Takeaways

CJC-1295 + Ipamorelin is the gold standard GH secretagogue stack — combining GHRH (amplitude) and GHRP (trigger) pathways for synergistic GH release
Standard dose: 100 mcg of each peptide per injection, SubQ, 1–3 times daily on an empty stomach
Fasting is essential — inject at least 2–3 hours after eating to avoid insulin-mediated GH suppression
Best injection time is before bed — synergizes with the natural nocturnal GH pulse for maximum effect
Use CJC-1295 WITHOUT DAC (Modified GRF 1-29) for this stack — the DAC version requires a different protocol
Typical cycle: 8–12 weeks on, 4 weeks off — no loading phase needed
Well-tolerated — Ipamorelin is the cleanest GHRP with no significant cortisol or prolactin elevation
Refrigerate reconstituted vials at 2–8°C and use within 28–30 days
No PCT required — this stack stimulates your own pituitary and does not suppress the natural GH axis
Neither peptide is FDA-approved for human use. Both are classified as research peptides and banned by WADA.

This article is for educational and informational purposes only. CJC-1295 and Ipamorelin are not approved by the FDA for human use and are classified as research peptides. They are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before using any research peptide, especially if you have pre-existing medical conditions, are taking medications, or are pregnant or nursing. See our Medical Disclaimer.

References

Bowers CY, et al. “On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.” Endocrinology. 1984;114(5):1537-1545.
Raun K, et al. “Ipamorelin, the first selective growth hormone secretagogue.” Eur J Endocrinol. 1998;139(5):552-561.
Ionescu M, Bhatt DL, et al. “Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.” J Clin Endocrinol Metab. 2006;91(12):4792-4797.
Teichman SL, et al. “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.” J Clin Endocrinol Metab. 2006;91(3):799-805.
Bowers CY. “Growth hormone-releasing peptide (GHRP).” Cell Mol Life Sci. 1998;54(12):1316-1329.
Ghigo E, et al. “Growth hormone-releasing peptides.” Eur J Endocrinol. 1997;136(5):445-460.
Veldhuis JD, et al. “Mechanisms and pathophysiology of the neuroendocrine control of growth hormone secretion.” Endocr Rev. 2009;30(2):152-177.

Next Steps

Continue your research with these resources.

CJC-1295 Dosage Guide

Complete individual dosing protocols, reconstitution, and injection guide for CJC-1295 (no DAC).

Read Guide

Ipamorelin Dosage Guide

Complete individual dosing protocols, timing, and safety for Ipamorelin as a standalone GHRP.

Read Guide

Dosage Calculator

Calculate exact doses for both peptides based on vial size and reconstitution volume.

Open Calculator